Skip to search formSkip to main contentSkip to account menu

Taxotere-Platinol-Fluorouracil Regimen

Known as: TPF, DCF, DCF Regimen 
A regimen consisting of docetaxel, cisplatin and fluorouracil used for the treatment of squamous cell head and neck cancer and gastric cancer.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
To report long‐term results of a randomized controlled trial that compared cisplatin/fluorouracil/docetaxel (TPF) induction… 
Highly Cited
2013
Highly Cited
2013
The combination of docetaxel, cisplatin, and 5‐fluorouracil (DCF) as preoperative treatment for esophageal squamous cell… 
Highly Cited
2010
Highly Cited
2010
BACKGROUND Concomitant chemoradiotherapy (CT/RT) is the standard treatment of locally advanced squamous cell carcinoma of the… 
Highly Cited
2005
Highly Cited
2005
While the impact of maternal morbidities and intrapartum procedures is a common topic in perinatal outcomes research, the… 
Highly Cited
2004
Highly Cited
2004
The microstructural basis for the mechanical properties of blood vessels has not been directly determined because of the lack of… 
Highly Cited
2002
Highly Cited
2002
A multiphoton microscope employing second-harmonic generation (SHG) and two-photon excited fluorescence (TPF) is used for high… 
Review
1999
Review
1999
PURPOSE The nucleoside analogs fludarabine, 2'-deoxycoformycin (DCF), and 2-chlorodeoxyadenosine (CdA), commonly used in the…